MICROBIOTIX
MicrobiotiX strives to develop treatments
for global intractable diseases such as multidrug-resistant
bacterial infections, autoimmune diseases and cancer
CDMO
Phage, Microbiome
& Beyond
CDMO SERVICE
01 | We provide specialized service that includes: product development, process optimization for bacteriophage drugs developed by consigned companies, technology transfer, aseptic vial filling for the production of drugs for clinical trial and for the drugs which has gone through the clinical trials. |
02 | Our production capabilities and quality assurance system fully comply with Good Manufacturing Practice (cGMP) and global regulations to provide highest quality of the product. |
03 | MicrobiotiX is developing a treatment for intractable multidrug-resistant bacteria through bacteriophage R&D for more than 15 years. We provide consignment research and production services based on cGMP manufacturing facilities dedicated to bacteriophage and long-term R&D know-how. |
Consignment production of Drug Substance (DS)
and Drug Product (DP)
MicrobiotiX complies with global regulations for the highest quality. We were also founded on the principle of delivering better CDMO services with speed and a competitive price. In line with this principle, microbiotix is trying to redefine the concept of what good customer satisfaction can be and provide the highest level of customer satisfaction, the likes of which the pharmaceutical industry has never seen before. We will provide reliable, high-quality services at all levels, from sterile filing and foreign contaminant inspection to packaging.
Aseptic filling Small/Large commercial and clinical |
Pre-shipment inspection Foreign substance inspection |
Quality control and storage application of pharmaceutical quality system (ICH Q10) |
CDMO
SERVICE
PROCEDURE
01
Research and production of bacteriophage clinical drug product or additives
02
Customized solution design through CMC expertise
03
Development of an optimized production process and quality control methods
04
Development and production scale-up in a cGMP facility
05
High quality drug product and analysis reports at a low cost
06
Reduced contracting costs and time
CDMO SERVICE
01 | We provide specialized service that includes: product development, process optimization for bacteriophage drugs developed by consigned companies, technology transfer, aseptic vial filling for the production of drugs for clinical trial and for the drugs which has gone through the clinical trials. |
02 | Our production capabilities and quality assurance system fully comply with Good Manufacturing Practice (cGMP) and global regulations to provide highest quality of the product. |
03 | MicrobiotiX is developing a treatment for intractable multidrug-resistant bacteria through bacteriophage R&D for more than 15 years. We provide consignment research and production services based on cGMP manufacturing facilities dedicated to bacteriophage and long-term R&D know-how. |
CDMO SERVICE PROCEDURE
01 Research and production of bacteriophage clinical drug product or additives |
02 Customized solution design through CMC expertise |
03 Development of an optimized production process and quality control methods |
04 Development and production scale-up in a cGMP facility |
05 High quality drug product and analysis reports at a low cost |
06 Reduced contracting costs and time |
MICROBIOTIX CO., LTD
IT Mirae Tower, 33, Digital-ro 9-gil, Geumcheon-gu, Seoul (60-21 Gasan-Dong, #304)
TEL : 02. 6379. 2649
E-mail : mx@microbiotix.net
Copyright © MICROBIOTIX. All rights reserved.
INQUIRIES |
MICROBIOTIX CO., LTD
IT Mirae Tower, 33, Digital-ro 9-gil, Geumcheon-gu, Seoul (60-21 Gasan-Dong, #304)
TEL : 02. 6379. 2649 l E-mail : mx@microbiotix.net
Copyright © MICROBIOTIX. All rights reserved.